Nasdaq GlobeNewswire

Lumenis Unveils the Pulse™ 30H, the State-of-the-Art Laser Solution Designed to Address Any Type and Size of Stone

Del

YOKNEAM, Israel, 2016-03-11 09:00 CET (GLOBE NEWSWIRE) -- Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced the launch of Lumenis Pulse 30H, the new addition to Lumenis’ comprehensive Urology portfolio, at the European Association of Urology (EAU) Congress, taking place March 11-15, 2016 in Munich.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/eebaf25f-74af-4dc8-9177-54732e90b31d

As the newest offering in its category, the Pulse 30H system has an energy per pulse of up to 5J, the highest of its kind, along with a repetition rate of 25Hz. These features contribute to reduced procedure duration, higher stone fragmentation rate and minimal retropulsion. These capabilities set it apart from competition and increase the variety of stone types and sizes addressed during procedures.

“I was extremely impressed by the comprehensive solution the Lumenis Pulse 30H provides in addressing stones of any type and size, as well as tumors,” said Dr. Guido Giusti, Urologist, Head of European Training Center in Endourology, Ospedale San Raffaele-Turro, Milan, Italy. “The system along with its fibers has definitely set a new standard in the mid/low power range of stone systems.”

Offering optimal user experience, the Lumenis Pulse 30H features an intuitive user interface, efficient and flexible space-saving design offered in tower or desktop, green aiming bean in five adjustment options for enhanced endoscopic visibility and a system’s setting summary report for 10 last treatments. Additionally, the Pulse 30H is aligned with Lumenis fibers, maximizing the fiber’s durability and energy utilization during procedures.

“With a history of innovation in the urology community, Lumenis’ holmium lasers and delivery devices are the standard of care in urology. Through our unique Pulse 120H product and the latest additions of Pulse 100H and Pulse 50H, we provide state-of-the-art offerings to various market segments,” said Tzipi Ozer-Armon, CEO of Lumenis. “By adding the Pulse 30H to our family of urology solutions, we are now offering a new best-in-class product in the low-watt segment, and look forward to continuing our commitment to deliver premium products to drive better treatment standards, and ultimately, enhance the quality of care for patients.”

To learn more about the Pulse 30H and Lumenis’ innovative laser technology, please visit the Lumenis booth #E10.

Additionally, Lumenis invites conference attendees to join a holmium panel discussion, “The importance of Holmium High Power / High Repetition to address BPH and stones,” with Professor Olivier Traxer, University of Paris 6th. Panelists will include: Mark Cynk, MD, Spire Turnbridge Wells Hospital; Rick Popert, MD, Guy’s and St. Thomas’ NHS Foundation Trust; Patrick De Geeter,MD, Klinikum Kassel; Tev Aho, MD, Nuffield Health Cambridge Hospital; Mark Leo, MD, Urology Specialists of Nevada; and Guido Giusti, MD, Ospedale San Raffaele-Turro. The panel will be held on Saturday, March 12, 6:00 - 7:30 PM in Room 13B (ICM, Level 1). Instructional courses on the Holmium laser techniques for BPH and stones are provided by Lumenis during EAU. For more information about Lumenis events at EAU, please visit:http://www.lumenis.com/Solutions/Surgical/News/Events/lumenis-at-eau16.

About Lumenis
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards.  Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. For more information visit:  www.lumenis.com

         For further information:
         
         Glenn Silver
         Lazar Partners Ltd.
         (646) 871-8495

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Partnership With FAST Technologies Expands Aptean's European Footprint17.1.2018 21:00Pressemelding

ALPHARETTA, Ga., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Aptean, a leading global provider of mission-critical enterprise software solutions, has formed a strategic partnership with FAST Technologies in Northern Ireland. This partnership is an important part of Aptean's growth strategy in the European market, specifically the United Kingdom and the Republic of Ireland. FAST Technologies will sell and support one of Aptean's industry-leading process solutions, Factory Manufacturing Execution System (MES). Process manufacturers use Factory MES to gain real-time visibility into production, operations and quality compliance by adopting a true paperless solution. FAST, a leading provider of industrial automation solutions, is well-established with high-volume manufacturers of retail packaged goods and pharmaceutical products. "We are excited to announce this partnership with Aptean. For many years, we have struggled with an appropriate solution that gives our customers an out-of-the-box experienc

Egyptian Steel recognised in the World Finance 100 guide for 201717.1.2018 15:29Pressemelding

LONDON, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Egyptian Steel currently stands as one of the most powerful companies in Egypt. Its prosperity is largely down to the work of founder and CEO, Ahmed Abou Hashima, whose optimistic and bold approach has seen the company go from strength to strength - even in tough conditions. In spite of Egypt's 2011 revolution, which pushed the country through much turmoil, Egyptian Steel was able to take off, having been founded just the year before. Abou Hashima believes that investors shouldn't be put off in times of political uncertainty and economic upheaval. If they are brave, the rewards can be great. And if his organisation's performance is anything to go by, it seems these are wise words; Egyptian Steel's four steel plants now produce 2.3 million tonnes of steel annually. For its outstanding work, Egyptian Steel has been recognised by World Finance in the magazine's World Finance 100 guide, which identifies the world's strongest organisations. Here, co

Investing in Berlin's thriving real estate market17.1.2018 15:05Pressemelding

LONDON , Jan. 17, 2018 (GLOBE NEWSWIRE) -- Germany's capital Berlin may be well known as a vibrant tourist destination - the city welcomed 12.7 million visitors last year - but it also offers fantastic investment opportunities. Currently, the real estate market is flourishing, but it is also constantly changing. As such, investors will find that a little market knowledge goes a long way. In 2018, the trend towards renting out furnished apartments looks set to continue, with renovated properties achieving a high sell-on value. Locations will also remain a key factor in determining property prices. In Berlin, real estate buyers will find that high-demand areas like Mitte, Prenzlauer Berg and Friedrichshain offer solid opportunities for return on investment (ROI). Alongside Berlin, other cities in former-East Germany are proving increasingly enticing to real estate developers. Leipzig, for example, has a thriving student population and good job prospects as a result of investment from Por

Innovative Humanized Research Strategies for Immuno-Oncology Drug Development, Crown Bioscience Hosts a Live Webinar17.1.2018 14:12Pressemelding

SAN DIEGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, will host a webinar on Thursday, January 18, 2018 at 10 am EST (3pm BST/UK), presented by renowned immunologist, Dr. Jayant Thatte. Dr. Thatte will review currently available humanized models and describe innovative applications for preclinical immuno-oncology research. The evaluation of immunotherapeutics is hindered by a lack of preclinical oncology models that exhibit functional human immunity. To overcome this obstacle, Crown Bioscience uses cutting-edge humanization protocols to develop innovative research solutions with reconstituted, functional human immune components. These humanized models can be combined with human cancer cell lines or patient-derived xenograft (PDX) mo

Colliers Launches Real Estate Technology Accelerator With Techstars17.1.2018 13:30Pressemelding

Partnership with Global Technology Investor and Accelerator Leader Highlights Commitment to Real Estate Industry Innovation TORONTO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (NASDAQ:CIGI) and (TSX:CIGI), a global leader in commercial real estate services, today announced the launch of the Colliers Proptech Accelerator powered by Techstars. "Disruptive changes in technology, evolving demographics, fierce global competition and increased connectivity are factors impacting all industries," said Dylan Taylor, Colliers President & COO. "And the commercial real estate industry is no exception. Colliers sees this as an opportunity and is committed to being the most enterprising company in our industry by developing innovative and value enhancing services for our clients and professionals. Partnering with Techstars allows us to harness the best and brightest in operating technology accelerators and selectively evaluate and invest in new technologies. The new Colliers

BnkToTheFuture Raises Initial $30 Million for Tokenized Securities Market and Due Diligence Platform17.1.2018 13:15Pressemelding

Largest Online Investment Platform for Fintech, Bitcoin, and Blockchain Ventures to Distribute BnkToTheFuture Token (BFT) for Equity-Backed Token Deals to Accredited Investors GEORGE TOWN, Cayman Islands, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Financial technology investment platform BnkToTheFuture (www.bnktothefuture.com) has raised an initial $30 million for its tokenized equity market and due diligence platform within the first 24 hours of of its token pre-sale open solely to institutional investors and members of its platform. BnkToTheFuture offers the largest online investment platform for investing in the equity of FinTech, Bitcoin, and Blockchain companies as well as Initial Coin Offerings (ICOs) that have passed a stringent due-diligence and compliance process. Already popular as an online investment platform with almost 50,000 professional and accredited investors with over $260 million invested in the funding rounds of FinTech, Bitcoin, and blockchain deals listed on its platform

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom